| Price | 0.25 |
| Price Change Today | 0.00 (0.00%) |
| P&P rating | ![]() |
| Zacks Rank | 3 - HOLD |
| Open Price | $0.00 |
| Previous Close | $0.25 |
| Daily Range | $0.00 - $0.00 |
| 52-Week Range | $0.14 - $1.99 |
| Volume | 0 |
| Emisphere Technologies is a biopharmaceutical company focused on the development of a family of oral heparin products; the application of proprietary synthetic chemical compounds to serve as carriers to facilitate the transport of therapeutic macromolecules and other compounds across biological membranes; and the development, in conjunction with the company's pharmaceutical collaborators, of oral formulations of selected therapeutic macromolecules. | |





Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment